Cargando…
Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity
Autores principales: | Gonzalez, Frank J., Jiang, Changtao, Bisson, William H., Patterson, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346267/ https://www.ncbi.nlm.nih.gov/pubmed/25747705 http://dx.doi.org/10.1016/j.jhep.2015.02.043 |
Ejemplares similares
-
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
por: Jiang, Changtao, et al.
Publicado: (2015) -
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
por: Zhang, Limin, et al.
Publicado: (2016) -
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
por: Wang, Xiaoxin X., et al.
Publicado: (2010) -
Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis
por: Wang, Hong, et al.
Publicado: (2018) -
Microbiota-induced obesity requires farnesoid X receptor
por: Parséus, Ava, et al.
Publicado: (2017)